Legend: 
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
|
404
|
Wed, 8/9/06, 10:30 AM - 12:20 PM
|
CC-2B
|
|
Dose-Finding - Topic Contributed - Papers
|
Biopharmaceutical Section, Biometrics Section, ENAR
|
|
Organizer(s): Naitee Ting, Pfizer Inc.
|
|
Chair(s): Naitee Ting, Pfizer Inc.
|
|
10:35 AM
|
Hypothesis Testing and Bayesian Estimation Applied to Sparse Dose Response Designs —  Neal Thomas
|
|
10:55 AM
|
Phase I Studies of Chemotherapeutic Agents in Cancer Patients: a Review of the Designs — Douglas Potter, University of Pittsburgh
|
|
11:15 AM
|
Design and Analysis of Dose-Finding Studies Combining Multiple Comparisons and Modeling Procedures — Frank Bretz, Novartis Pharma AG; Jose Pinheiro, Novartis Pharmaceuticals Corporation; Bjoern Bornkamp, University of Dortmund
|
|
11:35 AM
|
Optimal Dose Response Studies with Potentially Missing Observations — Weng Kee Wong, University of California, Los Angeles; InYoung Baek, Stony Brook University; Wei Zhu, Stony Brook University
|
|
11:55 AM
|
Experimental Design for Experiments with Toxicity and Efficacy Response Functions — Nancy Flournoy, University of Missouri-Columbia
|
|
12:15 PM
|
Floor Discussion
|
| |
